4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-025817
President and COO sold 12,500 shares at $23.01 ($287,591)
- President and COO acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2026-04-15 | Option exercise 10b5-1 | +8,000 | $3.79 | $30,318 | 208,641 | D |
| Cohlhepp Ryan President and COO | 2026-04-15 | Sale 10b5-1 | −8,000 | $23.01 | $184,058 | 200,641 | D |
| Cohlhepp Ryan President and COO | 2026-04-15 | Sale 10b5-1 | −4,500 | $23.01 | $103,533 | 196,141 | D |
| Derivatives | |||||||
| Cohlhepp Ryan President and COO | 2026-04-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,000 | 109,334 | D | ||
| Open-market sales · 12,500 sh · avg $23.01 · $287,591 | |||||||
Loading xslF345X06/wk-form4_1776459315.xml…